Lv2
140 积分 2022-03-04 加入
Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1/2 Study
30天前
已完结
453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: extended follow-up of a phase I/II study
30天前
已完结
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
30天前
已完结
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
2个月前
已完结
Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
2个月前
已完结
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
2个月前
已完结
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)
3个月前
已完结
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial
3个月前
已完结
皖公网安备34019202002308
